Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
47,716,597
-
Share change
-
+675,157
-
Total reported value
-
$623,208,206
-
Put/Call ratio
-
0%
-
Price per share
-
$13.06
-
Number of holders
-
92
-
Value change
-
+$5,067,526
-
Number of buys
-
32
-
Number of sells
-
44
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2021
As of 30 Sep 2021 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,716,597 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, BlackRock Inc., JANUS HENDERSON GROUP PLC, FEDERATED HERMES, INC., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, and STATE STREET CORP.
This table shows 93 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.